NASDAQ : TLSA
Tiziana Life Sciences Ltd — Financial statements
Healthcare · Biotechnology · United Kingdom
Last price 0.8 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 102.42M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 9.85M | 10.85M | 10.56M | 9.87M | 1.63M | 14.17M |
| Research & Development | 13.47M | 10.28M | 5.23M | 8.11M | 12.96M | 13.21M |
| Operating Expenses | 23.32M | 21.13M | 15.79M | 17.98M | 14.59M | 27.37M |
| Operating Income | -23.32M | -21.13M | -15.79M | -17.98M | -14.59M | -27.37M |
| Interest Expense | -18.00K | -18.00K | -10.00K | -7.00K | -176.00K | |
| Interest & Investment Income | 14.00K | 19.00K | 814.00K | 1.15M | 32.00K | |
| Other Non Operating Income (Expenses) | -328.00K | 33.00K | 893.00K | |||
| EBT Excluding Unusual Items | -23.65M | -21.13M | -14.98M | -16.84M | -14.53M | -26.66M |
| Gain (Loss) on Sale of Investments | -1.53M | 2.70M | -1.77M | -402.00K | -869.00K | |
| Pretax Income | -25.19M | -18.43M | -16.75M | -17.24M | -15.40M | -26.66M |
| Income Tax Expense | -4.88M | 449.00K | -3.24M | |||
| Net Income | -25.19M | -18.43M | -11.86M | -17.69M | -15.40M | -23.42M |
| Net Income to Common | -25.19M | -18.43M | -11.86M | -17.69M | -15.40M | -23.42M |
| Shares Outstanding (Basic) | 123.81M | 118.28M | 106.67M | 102.47M | 101.53M | 97.93M |
| Shares Outstanding (Diluted) | 123.81M | 118.28M | 106.67M | 102.47M | 101.53M | 97.93M |
| EPS (Basic) | -0.20 | -0.16 | -0.11 | -0.17 | -0.15 | -0.24 |
| EPS (Diluted) | -0.20 | -0.16 | -0.11 | -0.17 | -0.15 | -0.24 |
| Free Cash Flow | -13.46M | -12.87M | -1.54M | -15.70M | -19.61M | -21.78M |
| Free Cash Flow Per Share | -0.11 | -0.11 | -0.01 | -0.15 | -0.19 | -0.22 |
| EBITDA | -23.31M | -21.12M | -15.78M | -17.98M | -14.59M | -27.37M |
| D&A For EBITDA | 14.00K | 12.00K | 12.00K | 7.00K | 1.00K | 8.00K |
| EBIT | -23.32M | -21.13M | -15.79M | -17.98M | -14.59M | -27.37M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.18M | 4.01M | 3.72M | 1.18M | 18.12M | 42.19M |
| Cash & Short-Term Investments | 3.18M | 4.01M | 3.72M | 1.18M | 18.12M | 42.19M |
| Other Receivables | 4.32M | 4.08M | 3.64M | 5.93M | 5.86M | 5.27M |
| Receivables | 4.32M | 4.08M | 3.64M | 5.93M | 5.86M | 5.27M |
| Prepaid Expenses | 1.94M | 285.00K | 92.00K | 102.00K | 170.00K | 1.19M |
| Other Current Assets | 174.00K | 53.00K | 121.00K | 130.00K | 35.00K | |
| Total Current Assets | 9.44M | 8.55M | 7.51M | 7.34M | 24.28M | 48.68M |
| Property, Plant & Equipment | 985.00K | 499.00K | 187.00K | 293.00K | 389.00K | 17.00K |
| Long-Term Investments | 1.24M | 2.44M | 3.59M | 4.55M | 1.81M | |
| Other Intangible Assets | 130.00K | |||||
| Total Assets | 11.66M | 11.49M | 11.28M | 12.18M | 26.48M | 48.83M |
| Accounts Payable | 10.47M | 7.17M | 5.58M | 4.14M | 4.96M | 4.41M |
| Accrued Expenses | 2.65M | 3.29M | 1.65M | 2.25M | 1.57M | 1.77M |
| Current Portion of Leases | 106.00K | 222.00K | 106.00K | 138.00K | 122.00K | |
| Current Unearned Revenue | 343.00K | 530.00K | ||||
| Other Current Liabilities | 12.00K | -3.00K | 12.00K | 14.00K | 9.00K | 1.36M |
| Total Current Liabilities | 13.58M | 11.21M | 7.35M | 6.54M | 6.66M | 7.55M |
| Long-Term Leases | 826.00K | 234.00K | 109.00K | 243.00K | ||
| Total Liabilities | 14.41M | 11.44M | 7.35M | 6.65M | 6.91M | 7.55M |
| Common Stock | 128.00K | 121.00K | 111.00K | 103.00K | 102.00K | 102.00K |
| Additional Paid-In Capital | 43.44M | 34.66M | 23.11M | 16.49M | 15.60M | 15.60M |
| Retained Earnings | -175.50M | -163.11M | -144.83M | -133.68M | -116.26M | -108.06M |
| Treasury Stock | -1.57M | -1.32M | ||||
| Comprehensive Income & Other | 129.18M | 128.38M | 125.55M | 124.19M | 121.46M | 133.65M |
| Shareholders' Equity | -2.75M | 52.00K | 3.94M | 5.54M | 19.57M | 41.28M |
| Total Liabilities & Equity | 11.66M | 11.49M | 11.28M | 12.18M | 26.48M | 48.83M |
| Total Debt | 932.00K | 456.00K | 106.00K | 247.00K | 365.00K | |
| Net Cash (Debt) | 2.25M | 3.55M | 3.62M | 936.00K | 17.76M | 42.19M |
| Net Cash Per Share | 0.02 | 0.03 | 0.03 | 0.01 | 0.17 | 0.43 |
| Filing Date Shares Outstanding | 128.03M | 120.51M | 111.46M | 101.51M | 100.59M | 102.27M |
| Total Common Shares Outstanding | 128.03M | 120.51M | 111.46M | 101.51M | 100.59M | 102.27M |
| Working Capital | -4.14M | -2.66M | 160.00K | 798.00K | 17.62M | 41.13M |
| Book Value Per Share | -0.02 | 0.00 | 0.04 | 0.05 | 0.19 | 0.40 |
| Tangible Book Value | -2.75M | 52.00K | 3.94M | 5.54M | 19.57M | 41.15M |
| Tangible Book Value Per Share | -0.02 | 0.00 | 0.04 | 0.05 | 0.19 | 0.40 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -25.19M | -18.43M | -11.86M | -17.69M | -15.40M | -23.42M |
| Depreciation & Amortization | 304.00K | 234.00K | 124.00K | 96.00K | 51.00K | 141.00K |
| Loss (Gain) From Sale of Assets | 415.00K | 1.00K | 129.00K | -28.00K | ||
| Loss (Gain) From Sale of Investments | 2.07M | -1.75M | 1.76M | 402.00K | 869.00K | |
| Stock-Based Compensation | 2.59M | 4.54M | 5.97M | 2.30M | 1.81M | 6.03M |
| Provision & Write-off of Bad Debts | -166.00K | -166.00K | ||||
| Other Operating Activities | -484.00K | -336.00K | 3.04M | 779.00K | -5.91M | -3.71M |
| Change in Accounts Receivable | 692.00K | -378.00K | -1.47M | -1.52M | -1.16M | -88.00K |
| Change in Accounts Payable | -1.35M | -685.00K | ||||
| Change in Unearned Revenue | 337.00K | 530.00K | ||||
| Change in Other Net Operating Assets | 6.05M | 2.91M | 917.00K | -58.00K | 1.35M | |
| Operating Cash Flow | -13.38M | -12.85M | -1.53M | -15.70M | -19.61M | -21.76M |
| Capital Expenditures | -75.00K | -21.00K | -19.00K | -22.00K | ||
| Investment in Securities | 178.00K | 3.06M | -1.00M | -2.68M | ||
| Investing Cash Flow | 103.00K | 3.04M | -19.00K | -1.00M | -2.68M | 130.00K |
| Long-Term Debt Repaid | -196.00K | -141.00K | -119.00K | -55.00K | -152.00K | |
| Lease Payments | -278.00K | -196.00K | -141.00K | -119.00K | -55.00K | -152.00K |
| Net Debt Issued (Repaid) | -278.00K | -196.00K | -141.00K | -119.00K | -55.00K | -152.00K |
| Issuance of Common Stock | 9.39M | 10.15M | 4.65M | 24.00K | ||
| Repurchase of Common Stock | -52.00K | -253.00K | -1.32M | |||
| Other Financing Activities | 48.00K | 48.00K | 135.00K | 129.00K | ||
| Financing Cash Flow | 9.16M | 10.01M | 4.45M | -213.00K | -1.38M | -23.00K |
| Foreign Exchange Rate Adjustments | 47.00K | 84.00K | -367.00K | -28.00K | -398.00K | -1.98M |
| Net Cash Flow | -4.07M | 286.00K | 2.54M | -16.94M | -24.06M | -23.64M |
| Free Cash Flow | -13.46M | -12.87M | -1.54M | -15.70M | -19.61M | -21.78M |
| Free Cash Flow Per Share | -0.11 | -0.11 | -0.01 | -0.15 | -0.19 | -0.22 |
| Levered Free Cash Flow | -6.38M | -5.48M | -588.25K | -8.99M | -7.93M | -13.38M |
| Unlevered Free Cash Flow | -6.37M | -5.47M | -588.25K | -8.98M | -7.93M | -13.27M |
| Free Cash Flow After Leases | -13.73M | -13.06M | -1.69M | -15.82M | -19.67M | -21.94M |
| Cash Income Tax Paid | 75.00K | -8.78M | -490.00K | -1.42M | ||
| Change in Working Capital | 7.08M | 3.06M | -552.00K | -1.58M | -1.16M | -773.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 85.78M | 177.05M | 75.95M | 56.17M | 60.66M | 93.41M |
| Enterprise Value | 83.53M | 169.90M | 74.99M | 49.93M | 34.12M | 41.24M |
| Last Close Price | 0.67 | 1.49 | 0.70 | 0.56 | 0.60 | 0.96 |
| PB Ratio | 3,404.76 | 19.30 | 10.15 | 3.10 | 2.26 | |
| P/TBV Ratio | 3,404.76 | 19.30 | 10.15 | 3.10 | 2.27 | |
| Debt / Equity Ratio | -0.34 | 8.77 | 0.03 | 0.04 | 0.02 | |
| Net Debt / Equity Ratio | 0.82 | -68.35 | -0.92 | -0.17 | -0.91 | -1.02 |
| Net Debt / EBITDA Ratio | 0.10 | 0.17 | 0.23 | 0.05 | 1.22 | 1.54 |
| Net Debt / FCF Ratio | 0.17 | 0.28 | 2.34 | 0.06 | 0.91 | 1.94 |
| Quick Ratio | 0.55 | 0.72 | 1.00 | 1.09 | 3.60 | 6.29 |
| Current Ratio | 0.69 | 0.76 | 1.02 | 1.12 | 3.64 | 6.45 |
| Return on Equity (ROE) | -780.60% | -924.32% | -250.49% | -140.92% | -50.60% | -45.18% |
| Return on Assets (ROA) | -103.16% | -115.96% | -84.12% | -58.15% | -24.21% | -28.64% |
| Return on Capital Employed (ROCE) | 1,214.00% | -7,388.80% | -401.30% | -318.60% | -73.60% | -66.30% |
| Earnings Yield | -30.36% | -10.41% | -15.62% | -31.49% | -25.38% | -25.07% |
| FCF Yield | -15.69% | -7.27% | -2.03% | -27.95% | -32.33% | -23.32% |
| Buyback Yield / Dilution | -9.05% | -10.88% | -4.10% | -0.93% | -3.67% | -0.64% |